Skip to main content
Brendan Connell, MD, Oncology, Burlington, MA


Oncology Burlington, MA

Genitourinary Oncology, Thoracic Cancer


Dr. Connell is on Doximity

As a Doximity member you'll join over a million verified healthcare professionals in a private, secure network.

  • Connect with other colleagues in the same hospital or clinic
  • Search all U.S. specialist profiles and refer a patient
  • Read the latest clinical news and earn CME/CEU credits

See Dr. Connell's full profile

Already have an account?

Education & Training

  • Tufts Medical Center
    Tufts Medical CenterFellowship, Hematology and Medical Oncology, 2015 - 2018
  • Lahey Clinic
    Lahey ClinicChief Residency, Internal Medicine, 2014 - 2015
  • Lahey Clinic
    Lahey ClinicResidency, Internal Medicine, 2011 - 2014
  • Royal College of Surgeons Ireland
    Royal College of Surgeons IrelandClass of 2011
  • Harvard University
    Harvard UniversityBA, 2005

Certifications & Licensure

  • MA State Medical License
    MA State Medical License 2013 - 2022
  • American Board of Internal Medicine Internal Medicine
  • American Board of Internal Medicine Medical Oncology

Clinical Trials

Publications & Presentations



  • Fractionated docetaxel and radium-223 (Ra223) in metastatic castration-resistant prostate cancer (CRPC): A phase I trial.
    Brendan James Connell, Edmund Folefac, Clara Hwang, Christian Lawlor, Paul Mathew, GU ASCO 2021, 2/2021


  • Shifting patterns of care in localized prostate cancer: Impact on patient reported outcome measures (PROMs). 
    2019 ASCO Annual Meeting - 6/1/2019